These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23065782)

  • 1. Covalent incorporation and controlled release of active dexamethasone from injectable polyethylene glycol hydrogels.
    Bezuidenhout D; Oosthuysen A; Davies N; Ahrenstedt L; Dobner S; Roberts P; Zilla P
    J Biomed Mater Res A; 2013 May; 101(5):1311-8. PubMed ID: 23065782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inner ear delivery of dexamethasone using injectable silk-polyethylene glycol (PEG) hydrogel.
    Yu D; Sun C; Zheng Z; Wang X; Chen D; Wu H; Wang X; Shi F
    Int J Pharm; 2016 Apr; 503(1-2):229-37. PubMed ID: 26972377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subconjunctival injectable dendrimer-dexamethasone gel for the treatment of corneal inflammation.
    Soiberman U; Kambhampati SP; Wu T; Mishra MK; Oh Y; Sharma R; Wang J; Al Towerki AE; Yiu S; Stark WJ; Kannan RM
    Biomaterials; 2017 May; 125():38-53. PubMed ID: 28226245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled release of dexamethasone from poly(vinyl alcohol) hydrogel.
    Long J; Nand AV; Bunt C; Seyfoddin A
    Pharm Dev Technol; 2019 Sep; 24(7):839-848. PubMed ID: 30932724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved vascularization of porous scaffolds through growth factor delivery from heparinized polyethylene glycol hydrogels.
    Janse van Rensburg A; Davies NH; Oosthuysen A; Chokoza C; Zilla P; Bezuidenhout D
    Acta Biomater; 2017 Feb; 49():89-100. PubMed ID: 27865963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradable poly(ethylene glycol) (PEG)-based hydrogels for spatiotemporal control of siRNA/nanoparticle delivery.
    Wang Y; Zhang S; Benoit DSW
    J Control Release; 2018 Oct; 287():58-66. PubMed ID: 30077736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradable dextran hydrogels: controlled release of a model protein from cylinders and microspheres.
    Franssen O; Vandervennet L; Roders P; Hennink WE
    J Control Release; 1999 Aug; 60(2-3):211-21. PubMed ID: 10425327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of model proteins and basic fibroblast growth factor from in situ forming degradable dextran hydrogels.
    Hiemstra C; Zhong Z; van Steenbergen MJ; Hennink WE; Feijen J
    J Control Release; 2007 Sep; 122(1):71-8. PubMed ID: 17658651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended delivery of ophthalmic drugs by silicone hydrogel contact lenses.
    Kim J; Conway A; Chauhan A
    Biomaterials; 2008 May; 29(14):2259-69. PubMed ID: 18289662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A designed supramolecular cross-linking hydrogel for the direct, convenient, and efficient administration of hydrophobic drugs.
    Yu B; Zhan A; Liu Q; Ye H; Huang X; Shu Y; Yang Y; Liu H
    Int J Pharm; 2020 Mar; 578():119075. PubMed ID: 31991187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimising the controlled release of dexamethasone from a new generation of PLGA-based microspheres intended for intravitreal administration.
    Rodríguez Villanueva J; Bravo-Osuna I; Herrero-Vanrell R; Molina Martínez IT; Guzmán Navarro M
    Eur J Pharm Sci; 2016 Sep; 92():287-97. PubMed ID: 26987610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone-loaded injectable silk-polyethylene glycol hydrogel alleviates cisplatin-induced ototoxicity.
    Chen Y; Gu J; Liu J; Tong L; Shi F; Wang X; Wang X; Yu D; Wu H
    Int J Nanomedicine; 2019; 14():4211-4227. PubMed ID: 31239676
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel degradable poly(ethylene glycol) hydrogels for controlled release of protein.
    Zhao X; Harris JM
    J Pharm Sci; 1998 Nov; 87(11):1450-8. PubMed ID: 9811505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrogel-mediated local delivery of dexamethasone reduces neuroinflammation after traumatic brain injury.
    Jeong DU; Bae S; Macks C; Whitaker J; Lynn M; Webb K; Lee JS
    Biomed Mater; 2021 Feb; 16(3):. PubMed ID: 33152711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone-functionalized gels induce osteogenic differentiation of encapsulated hMSCs.
    Nuttelman CR; Tripodi MC; Anseth KS
    J Biomed Mater Res A; 2006 Jan; 76(1):183-95. PubMed ID: 16265650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone released from cochlear implant coatings combined with a protein repellent hydrogel layer inhibits fibroblast proliferation.
    Wrzeszcz A; Dittrich B; Haamann D; Aliuos P; Klee D; Nolte I; Lenarz T; Reuter G
    J Biomed Mater Res A; 2014 Feb; 102(2):442-54. PubMed ID: 23533184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled release of dexamethasone from peptide nanofiber gels to modulate inflammatory response.
    Webber MJ; Matson JB; Tamboli VK; Stupp SI
    Biomaterials; 2012 Oct; 33(28):6823-32. PubMed ID: 22748768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained release of multicomponent platelet-rich plasma proteins from hydrolytically degradable PEG hydrogels.
    Jain E; Sheth S; Dunn A; Zustiak SP; Sell SA
    J Biomed Mater Res A; 2017 Dec; 105(12):3304-3314. PubMed ID: 28865187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated delivery of glucocorticoids from thiol-ene hydrogels.
    Yang C; Mariner PD; Nahreini JN; Anseth KS
    J Control Release; 2012 Sep; 162(3):612-8. PubMed ID: 22902591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronic acid-based hydrogels containing covalently integrated drug depots: implication for controlling inflammation in mechanically stressed tissues.
    Xiao L; Tong Z; Chen Y; Pochan DJ; Sabanayagam CR; Jia X
    Biomacromolecules; 2013 Nov; 14(11):3808-19. PubMed ID: 24093583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.